What industry says


Intel has enjoyed a long-standing relationship with Tyndall since it first set up a manufacturing site in Ireland in 1989. The relationship has matured over time and is now firmly built on collaboration and productive partnership.

In 2010, Intel commenced a major research programme with Tyndall, which was renewed in 2012 when Intel announced a further commitment to invest $1.5 million in research to be carried out at Tyndall over a three-year term. The initial programme produced some very useful outcomes for Intel across a range of challenging topics in areas such as photonics, device modelling and new material development.

The current agreement to run from 2013 - 2015 again provides Intel with a commercial exploitation license to technology created through the collaboration with Tyndall.

Dr. Mike Mayberry, Director of Components Research in Portland Oregon said “Through their publications and technology, Tyndall researchers continue to demonstrate their ability to innovate and invent technologies that could potentially advance the frontiers of semiconductor technology”.

Lake Region
Lake Region Medical International Research and Development Centre is the Galway-based Irish subsidiary of Massachusetts-based Lake Region Medical, the world’s largest manufacturer of medical guidewires for the cardio and vascular and advanced surgical markets.

Lake Region Medical chose to partner with the Irish Photonic Integration Centre (IPIC) and Tyndall, because of its reputation for research in the field of photonics, sensors, nanotechnology and miniaturisation. The partnership will run until at least 2016, with successful commercialisation leading to the creation of additional jobs in a rapidly growing medical device market segment worth almost €2 billion annually.

In 2014, Lake Region Medical successfully displayed prototypes representing the project to date at the TCT international Conference organised by the Cardiovascular Research Foundation of America, held in Washington DC. Dr John Hayes said, “The output from our first project at Tyndall is very encouraging and Lake Region Medical is looking forward to a long and fruitful relationship with Tyndall.”

Brockley Group
Brockley Group, headquartered in Dublin, is an indigenous SME that supplies major manufacturers from around the world with both commodity and specialised chemicals and environmental fluid BlueCat AdBlue®

Brockley Group is in the business of delivering the high volume low value environmental solutions BlueCat AdBlue® which are stored in tanks on clients premises.

The gap identified by Holmes was for an accurate, lowcost, measuring device to help better manage tank content via remote monitoring.

Brockley’s relationship with Tyndall marked a new departure for the Group in more ways than one. It will result in the launch of a smart product to complement its core business – the supply of chemical solutions - but it also represented the first time it worked with a research institute.

Nicky Holmes said, “As an SME we tended to do what other traditional SMEs do, keep our heads down and run our business. We trundled along for years with little resources. We never looked up to investigate what other markets we could compete in, and with what products. Working with Tyndall gave us the opportunity to helicopter above our normal world to see a far bigger horizon.” 

United Technologies Research Centre
United Technologies Research Centre (UTRC) established in Cork in 2010 as the European corporate research hub for United Technologies Corp. (UTC), a $65 billion US headquartered multinational corporation, providing high technology systems and services to the building and aerospace industries.

One of the key factors that attracted UTRC-Ireland to Cork was its proximity to leading research institutes, including Tyndall National Institute with its high-quality researchers, facilities and graduates.

In 2014, UTRC-Ireland successfully partnered with Tyndall as the Irish consortium within the EU-funded project SAFESENS, where together they are developing next-generation fire safety and building evacuation technology.

Dr. Phil Harris, Group Leader, Networks & Embedded Systems, UTRC-Ireland, acknowledged, “Based on this experience, we are continually looking for additional opportunities to partner with Tyndall to support our internal research agenda and to address large-scale European research opportunities, and we expect this partnership to continue growing over the long term.”

Founded in Galway in 1997, Aerogen specialises in the design, manufacture and marketing of aerosol drug delivery systems aimed at

the critical care respiratory market. Its products are used to treat patients on lifesupport ventilation in over 65 countries worldwide.

Aerogen invests heavily in its R&D in order to evolve and extend its product range. To this end it built strategic alliances with Tyndall, to enable it to leverage home grown scientific excellence to facilitate its rapid growth.

Dr. Ronan MacLoughlin, Senior Scientist with Aerogen said “My experience with Tyndall researchers thus far is that they are amongst the most productive and “industry savvy” I have ever come across in all my interactions with academic institutions from around the world. The researchers appreciate my approach and understand the requirement for rapid progress, and the reporting of same. They are exceptionally knowledgeable in their respective fields and have the capacity to apply that knowledge in other applications. This is not a common thing.”

Aerogen is currently working with Tyndall on new projects.

Analog Devices
Analog Devices Incorporated (ADI) has been in business in Ireland for the past 30 years and currently employs over 1,000 people here. The company is a leading manufacturer of very high precision analog, mixed signal, Digital Signal Processing (DSP) and RF integrated circuits (ICs) used in electronic equipment.

Tyndall’s relationship with industry partner Analog Devices dates back to 1982, when the Institute was known as the NMRC (National Microelectronics Research Centre). Over the years the two organisations have collaborated on a number of projects together. Bill Lane, Director Process Development – Ireland said “The projects we run in Tyndall are designed to explore process technologies we don’t currently know anything about, in other words emerging new technologies. What we get is a very early introduction and the opportunity to investigate what would be required to bring these new technologies into manufacturing. We have licensed or acquired several new technologies over the years from Tyndall/NMRC. Tyndall has the people to help explore those unknown places with us.”


Eblana Photonics
Eblana Photonics is a lead supplier of laser components to EU sponsored research projects and has developed solid links with Tyndall because of their expertise in laser physics and semiconductor device fabrication.

CEO Jim Somers recognises that Tyndall’s capabilities and facilities have improved especially in Photonics and Photonics integration. “The research work that Tyndall is carrying out for us in the area of photonics is very important for us and that’s what made us decide to partake in the Irish Photonic Integration Centre (IPIC) programme at Tyndall”. He adds, “Some of the individual researchers, people like Frank Peters, Peter O’Brien and Brian Corbett within Tyndall are highly regarded experts in their fields worldwide, and to be able to tap into this and literally have it on our doorstep is very significant.” 


PMD Solutions
Established in 2011, PMD Solutions (PMD) is a Cork-based company, with Enterprise Ireland ‘High Potential Start Up’ status. This endorsement recognises the global sales potential of PMD’s products and its vision of establishing their premier product ‘RespiraSense’ as the global industry standard in respiratory rate monitoring.

Myles Murray, CEO of PMD Solutions explains “PMD first engaged with Tyndall in 2012 and their subsequent input at that stage, supported the growth of the company from idea to concept validation. What attracted us in the first instance was their innovative modular electronic platform. Since then, PMD has committed to sponsor Tyndall in a Science Foundation Ireland funded initiative to develop pipeline products that add value to the healthcare community.”

According to Myles Murray, “When it comes to the transfer of technology from academia to industry, Tyndall is ahead of the curve. They have a strong focus on commercialising technology with industry partners that add value to the world.” 


Boston Scientific
Established in Ireland in 1994, Boston Scientific has grown to be the largest medical device employer in Ireland. The Irish manufacturing operation is an integral part of the corporation’s manufacturing strategy and capability. Such is its commitment to R&D and innovation, that it invests $1bn annually in new products and technologies

Boston Scientific started working with Tyndall National Institute in 2013. Outlining what attracted them to Tyndall, Michael Kane, Fellow, Process Development says, “Tyndall has a good reputation as a technological centre, so they were already on our radar. They are especially well regarded for their capabilities in the areas of micro-fabrication, integrated circuit analysis, and reliability domains, plus they have the ability to branch into different applications around those technologies.”

The skills and strengths that Tyndall can leverage for the medtech sector may not be immediately obvious to those outside the sector, but those working within it can appreciate what Tyndall has to offer. “With medical devices, the part that most people focus on is the interface to the body and to medicine, but that’s like looking at the pacemaker from the outside only,” observes Kane. “If you look deeper into the pacemaker, it’s about sophisticated electronics: precision circuits, clinical algorithms, bio-sensors and radio communications, all of it contained within this €2 coin-sized pacemaker. Those are perfect matches for the excellent technologies on campus at Tyndall, especially the MCCI working group at Tyndall.”


M/A-COM Technology Solutions (MACOM) is a leading provider of high performance analog semiconductor solutions for use in wireless and wireline applications across the radio frequency (RF), microwave and millimeterwave spectrum. With a heritage in the RF industry that dates back to 1950, it designs and manufactures standard and custom devices, integrated circuits, components, modules, and sub-systems for customers who demand high performance, quality and reliability.

MACOM has enjoyed a long working relationship with Tyndall National Institute. According to David Ryan, Business Development Manager, “We recognise Tyndall’s standing as a leader in the field of photonics and we appreciate the quality of skills available at Tyndall. We hold Tyndall in high esteem and are delighted to have such an excellent resource so close by.” 

According to David Ryan, “Being able to demonstrate the benefits we gain from access to the resources at Tyndall has helped MACOM’s Cork base strengthen its hand when it comes to making a continued case for investment and growth with the company.” 


X-Celeprint, headquartered in Tyndall National Institute, Cork, is the developer and sole licensor of patented Micrp-Transfer-Printing (μTP ) technology. Originally invented in Professor John Roger’s laboratory at the University of Illinois, μTP is a cost-effective and scalable manufacturing platform which can have a far-reaching impact on reducing assembly and manufacturing costs for electronic and photonic devices or enabling new applications.

CEO Kyle Benkendorfer says the decision to locate at Tyndall was simple. “We had two large potential customers who recommended that we check out Tyndall. When we did, we were very impressed by the people, the work going on here and the facilities.” Locating in Tyndall makes good commercial sense for X-Celeprint. “We need access to special facilities, and being on campus allows us to leverage excellent facilities without investing in costly equipment.”


Anvil Semiconductors
Conventional, cheap and proven silicon devices are used to switch and control power in electrical systems. However, Silicon Carbide (SiC) devices are considerably more efficient but ten times more expensive.

That’s about to change thanks to the design of SiC devices from Anvil Semiconductors who will offer a far superior performance to conventional silicon, at the same price. Anvil-Semiconductors partnership with Tyndall has helped them move along this commercial process.

CEO Jill Shaw explained “Although Tyndall didn’t have the direct silicon carbide experience we wanted, they have considerable experience in device fabrication in Si and compound semiconductors. They had the facilities we required and were willing to take on the challenge to quickly climb the learning curve,”

Looking to the future, she says, “Tyndall can accommodate small production batches which are a real advantage for us. We don’t view this as a one-off job, we anticipate a long-term relationship and we already have an ongoing contract in place.”


Radisens Diagnostics
Radisens Diagnostics has developed a pioneering point-of-care diagnostic platform that breaks new ground in the decentralisation of routine blood tests, moving them from laboratories into the GPs’ surgeries, hospital bedsides and other point-of-care settings.

Radisens first engaged with Tyndall in 2012, initially through a very successful Enterprise Ireland sponsored Innovation Partnership project, the outcome of which the company is currently building upon. CEO Jerry O’Brien says, “From there, we have extended the relationship through our participation in the Irish Photonic Integration Centre (IPIC) at Tyndall, within which Tyndall is working on a multi-year targeted project for us.”

He is impressed by the level of expertise at Tyndall. “The Principal Investigator at Tyndall, which leads our collaboration, has several years of relevant industry and start-up experience. Therefore, the Tyndall team has a great understanding of industry needs coupled with a practical can-do attitude.”

Looking to the future, Jerry O’Brien is in no doubt that the relationship between Radisens and Tyndall will continue and evolve. “The IPIC framework is much more flexible and industry friendly than any previous academic/industry collaboration mechanism that I have seen. We are already exploring follow-on projects.”


United Tecnolologies
"Establishing a hub for European collaboration in Ireland will help accelerate technologies addressing renewable energy, energy efficiency, and integrated building systems. Taking advantage of Ireland's agility, as well as Europe's commitment to 'clean' technology, we intend to demonstrate emerging technologies on a scale ranging from individual buildings to district-wide applications."

David Parekh, Vice President, Research, and Director, United Technologies Research Centre – on the occasion of the announcement by UTRC on setting up its European HQ at Tyndall.


Firecomms - a ZJF Group Company
“Our initial research in Tyndall was brought to a level of maturity before we spun-out the technology in 2001. Since then we have always maintained a deep and highly productive collaboration with the Photonics group in Tyndall. The ZJF Group is very aware of the depth of resources available at Tyndall which will continue to play a key role in our future R&D investments.”

John D. Lambkin, CTO and co-founder of Firecomms


BiancaMed Ltd.
“We have been at a critical stage in our development and had a need for access to test facilities and associated expertise at Tyndall. These facilities and expertise are not otherwise available on the island of Ireland. Our experience at Tyndall was indeed world class and in my view, Tyndall represents a very valuable national asset (not just for expertise but also attitude) – this will certainly make a great difference to our success.”

Colin Lawlor, CEO, BiancaMed Ltd.


Royal College of Surgeons in Ireland
“This unique collaboration between RCSI and Tyndall, the first of its kind in Ireland, will enable the application of fabrication techniques and products traditionally used in ICT hardware to be used in healthcare applications, to ultimately improve patient care and outcomes and enable faster recovery time for patients due to less invasive surgery, as well as reducing healthcare costs.”

Professor Cathal Kelly, CEO / Registrar, RCSI – on the occasion of the signature of the Memorandum of Understanding between Tyndall and RCSI.


Peter Smyth
Tel: +353 21 234 6605
Mob: + 353 87 241 7410
Email: peter.smyth@tyndall.ie 

Hugh Smiddy 
Tel: +353 (0) 21 234 6697  
Mob: +353 (0) 87 370 7059
Email: hugh.smiddy@tyndall.ie 

Carlo Webster
Tel: +353 (0)21 234.62.53
Mob: +353 (0)87 250.91.48
Email: carlo.webster@tyndall.ie 

Ireland fund ecsf ucc
Privacy - Legal Statements
Tyndall - All rights reserved - 2018